Phase 2 Colorectal Cancer Trial, Recruiting NCT06050707 Sponsor: University Health Network, Toronto Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 2 Colorectal Cancer Trial, Recruiting

NCT06050707
Recruiting Phase 2 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with squamous cell carcinoma (a type of cancer) of the anal canal or anal margin, confirmed by a tissue test. This includes certain related cancer cell types (such as basaloid or cloacogenic).
  • People whose cancer is at a stage that has not spread to distant parts of the body, based on standard cancer staging guidelines (confirm with trial site).
  • People whose treating doctor considers them suitable for radiation therapy, either alone or combined with chemotherapy, as their main treatment.
  • People who are 18 years of age or older.
  • People who are reasonably active and able to care for themselves, as measured by a standard medical scoring tool called the ECOG performance scale (scores 0–2, meaning fully active to capable of self-care but unable to do heavy physical work).

Who may not be able to join:

  • People who have previously received chemotherapy, radiation therapy, or major surgery intended to cure their anal cancer.
  • People who have previously had radiation therapy to the abdomen or pelvis in a way that would overlap with the radiation treatment area used in this trial.
  • People who have a history of another type of cancer, unless they have been free of that cancer for at least 2 years and their doctor considers the risk of it returning to be low. An exception applies for people diagnosed and treated within the past 5 years for cervical cancer in situ, or basal cell or squamous cell carcinoma of the skin — those people may still be considered eligible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 416-946-2360

Australian sites

Austin Health, Heidelberg, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
29 September 2023
Est. completion
1 September 2028

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in locoregional failure (LRF) at Year 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov